Project

/in /by

APA format project 

discussion week 3

/in /by

Nursing assignment

/in /by

Asssigment

/in /by

 

Concept Map

/in /by

Please see attachment

NR507 Week 4 Collaboration Response MR

/in /by

response is needed

Hello everyone, 

Describe the specific pathophysiological processes in SLE that lead to the manifestations observed in your assigned body system. How does SLE affect your assigned body system?

     Systemic Lupus Erythematosus (SLE) is an autoimmune disease that affects the pulmonary system mainly through inflammation. Autoantibodies and immune complexes attack lung tissue, causing pleuritis, Interstitial Lung Disease (ILD), and pulmonary hypertension (Shin et al., 2022). Symptoms of pleuritis include acute chest aches and labored breathing. For pulmonary system, scarring and inflammation from ILD induce lung rigidity, which impairs gas exchange. 

Discuss the symptoms and clinical manifestations of SLE on your assigned body system. How do these symptoms impact the client’s function and quality of life? Can changes in your assigned body system affect or be affected by other body systems in clients with SLE?

     Cough, dyspnea, chest pain, and weariness are SLE pulmonary symptoms. These symptoms limit mobility and lower the client’s quality of life, making walking or stair climbing difficult (Depascale et al., 2021). Interstitial lung illness can cause fatigue and reduced exercise tolerance, like chronic hypoxia. Pulmonary changes can be linked to cardiovascular stress in right-sided heart failure patients with pulmonary hypertension. If only the renal, cardiovascular, and immune systems are inflamed, pulmonary changes can increase systemic inflammation. This reciprocal body structure activation worsens SLE treatment. 

Discuss the diagnostic tests used to diagnose SLE-related complications in your body system. What challenges are associated with diagnosing SLE if only looking at your assigned body system?

      Imaging and functional testing are needed to diagnose pulmonary involvement in SLE. High-resolution Computed Tomography (CT) scans or chest X-rays are needed to confirm chest opacities, pleural effusion, or lung fibrosis in suspected interstitial lung disease. Pulmonary Function Tests (PFTs) of lung volume and diffusing capacity can also confirm interstitial lung disease (Zamboti et al., 2021). Diagnosing SLE through the pulmonary system is quite challenging since its symptoms are very much related to asthma.

Explore the current treatments for managing SLE symptoms associated with your assigned body system. What are the goals of these treatments, and how effective are they in mitigating the impact of SLE on the body?

      SLE pulmonary manifestations require inflammation control, lung tissue preservation, and symptom suppression. Corticosteroids like prednisone are anti-inflammatory. Medications like mycophenolate mofetil and azathioprine weaken the immune system. Sildenafil and other vasodilators treat pulmonary hypertension. Continuous oxygen supply is also sometimes required for chronic hypoxic conditions (Agarwal et al., 2021). The main goal of this medicines is to manage the disease and slow its progression but cannot repair the damage. They are effective in a way they protect lung function and minimize SLE’s health impacts. 

References

Agarwal, T., Kazemi, S., Costantini, M., Perfeito, F., Correia, C. R., Gaspar, V., Montazeri, L., De Maria, C., Mano, J. F., Vosough, M., Makvandi, P., & Maiti, T. K. (2021). Oxygen releasing materials: Towards addressing the hypoxia-related issues in tissue engineering. Materials Science and Engineering: C, 122, 111896. https://doi.org/10.1016/j.msec.2021.111896Links to an external site. 

Depascale, R., Del Frate, G., Gasparotto, M., Manfrè, V., Gatto, M., Iaccarino, L., Quartuccio, L., De Vita, S., & Doria, A. (2021). Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: A literature review. Therapeutic Advances in Musculoskeletal Disease, 13, 1–24. https://doi.org/10.1177/1759720x211040696Links to an external site. 

Shin, J. I., Lee, K. H., Park, S., Yang, J. W., Kim, H. J., Song, K., Lee, S., Na, H., Jang, Y. J., Nam, J. Y., Kim, S., Lee, C., Hong, C., Kim, C., Kim, M., Choi, U., Seo, J., Jin, H., Yi, B., & Jeong, S. J. (2022). Systemic lupus erythematosus and lung involvement: A comprehensive review. Journal of Clinical Medicine, 11(22), 6714. https://doi.org/10.3390/jcm11226714Links to an external site. 

Zamboti, C. L., Cristina, A., Garcia, T., Krinski, G. G., Bertin, L. D., Almeida, S., Pimpão, H. A., Fujisawa, D. S., Ribeiro, M. A., Pitta, F., & Camillo, C. A. (2021). Functional performance tests in interstitial lung disease: Impairment and measurement properties. Respiratory Medicine, 184, 106413. https://doi.org/10.1016/j.rmed.2021.106413

Week 4 NR507 Collaboration Cafe response KPM

/in /by

Need a response 

Good Afternoon Dr. Giner and Classmates my designated system for this discussion is the cardiovascular system, one of my favorites.

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. In the cardiovascular system, this autoimmune response can result in several pathophysiological processes:

  • Pericarditis: Inflammation of the pericardium, the membrane surrounding the heart, is the most common cardiac manifestation in SLE patients. This condition can cause chest pain and may lead to pericardial effusion. 
  • Accelerated Atherosclerosis: SLE is associated with an increased risk of premature atherosclerosis, leading to coronary artery disease. Chronic inflammation and immune complex deposition contribute to endothelial damage, promoting plaque formation. 
  • Libman-Sacks Endocarditis: This nonbacterial form of endocarditis involves the formation of sterile vegetations on heart valves, particularly the mitral and aortic valves. These vegetations can lead to valvular dysfunction and increase the risk of thromboembolic events. 

Cardiovascular involvement in SLE can present with different symptoms like Chest Pain Often resulting from pericarditis, patients may experience sharp, pleuritic chest pain that worsens with deep breaths or lying down. Dyspnea can occur due to pericardial effusion or heart failure secondary to myocarditis or coronary artery disease and  Palpitations with Arrhythmias may arise from myocardial involvement or valvular disease.

These cardiovascular manifestations can significantly impact a patient’s daily functioning and quality of life, leading to reduced exercise tolerance, have chronic pain, and anxiety. In addition, cardiovascular complications can affect renal function by altering hemodynamics or contributing to cerebrovascular events by causing embolisms.

Diagnosing cardiovascular involvement in SLE involves a combination of clinical evaluation and diagnostic testing:

  • Echocardiography is  important and essential for pericardial effusion, valvular vegetations indicative of Libman-Sacks endocarditis, and assessing myocardial function.
  • Electrocardiogram (ECG) is  useful for identifying arrhythmias, conduction Issues, and abnormalities, or signs of myocardial ischemia.
  • Cardiac MRI can provide detailed imaging to assess myocardial inflammation, fibrosis, and pericardial involvement.
  • Coronary Angiography is sometimes indicated when there is suspicion of coronary artery disease to evaluate the extent of atherosclerosis.

Challenges in diagnosing SLE-related cardiovascular complications include the overlap of symptoms with other conditions, such as infections or primary cardiac diseases.

Current Treatments and Management of cardiovascular manifestations in SLE focuses on controlling inflammation, preventing disease progression, and addressing specific cardiac issues:

  • Anti-inflammatory and Immunosuppressive Therapies: Medications such as corticosteroids and immunosuppressants are used to reduce systemic inflammation and autoantibody production,  mitigating cardiovascular involvement. 
  • Hydroxychloroquine: Has been shown to have cardioprotective effects in SLE patients, reducing disease flares and potentially decreasing the risk of thrombosis.
  • Cardiovascular Risk Management: Addressing traditional risk factors through lifestyle modifications, statin therapy for dyslipidemia, antihypertensive treatment, and antiplatelet agents can help prevent atherosclerosis progression.
  • Surgical Interventions: In cases of severe valvular disease due to Libman-Sacks endocarditis, surgical repair or replacement may be necessary.

The goal of these treatments is to control disease activity, prevent organ damage, and improve overall survival. While advancements in therapy have improved outcomes, cardiovascular disease remains a leading cause of morbidity and mortality in SLE patients, highlighting the need for ongoing monitoring and comprehensive care.

References:

 Hopkins Lupus. (n.d.). How lupus affects the cardiovascular system. Johns Hopkins Lupus Center. Retrieved from https://www.hopkinslupus.org/lupus-info/lupus-affects-body/lupus-cardiovascular-system/

Ibrahim, A. M., & Siddique, M. S. (2023). Libman-Sacks Endocarditis. In StatPearls. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK532864/Links to an external site.

Johansson, A., & Gustafsson, J. T. (2022). Systemic lupus erythematosus and cardiovascular disease: Mechanisms and clinical implications. Journal of Internal Medicine, 291(2), 189-208. https://doi.org/10.1111/joim.13557

MedlinePlus. (n.d.). Systemic lupus erythematosus (SLE). U.S. National Library of Medicine. Retrieved from https://medlineplus.gov/ency/article/000435.htm

  • Reply to post from Katia Pena Morales
     

Strategic Planning

/in /by

Attached 

Haitian Discussion (response to classmate)

/in /by

This is the discussion post:

The St. Fleur family is well respected in the Haitian community because they are religious with great moral values. They moved to the United States because of political issues in Haiti. Ronald, the youngest son of this family, is 27 years old and lives at home with his mother and father. Recently, he began having fevers and subsequently developed pneumonia. He was admitted to the hospital, where laboratory tests were HIV positive. Ronald was in shock when the doctor informed him that he was HIV positive. He confessed to the doctor that he was gay but he could not tell his family. He said that he did not want to bring shame to the family. Because he couldn’t be in a formal relationship owing to his family and the Haitian community’s view of homosexuality, he has been very promiscuous over the years.

  1. What are Haitians’ dominant cultural views of homosexuality?
  2. If Ronald’s parents were to learn of his positive HIV status, how might they react if they are religious and traditional?
  3. Identify three specific culturally congruent strategies to address in designing HIV-prevention practices in the Haitian community.

– I have to respond to two lead postings. Each response must have a reference that does not come from the textbook. 

-Below I will attach the 2 posts I will reply to. 

Comprehensive Psychiatric Evaluation 2

/in /by

this one will should be done on a patient that is 5-13 years old